NCT01722656View on ClinicalTrials.gov

Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Submacular Vascularized Pigment Epithelial Detachments
Interventions
DRUG

Aflibercept

Trial Locations (3)

57701

Black Hills Regional Eye Institute, Rapid City

90095

Jules Stein Eye Institute, Los Angeles

92211

Southern California Desert Retina Consultants, Palm Desert

All Listed Sponsors
collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Southern California Desert Retina Consultants, MC

OTHER

NCT01722656 - Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment | Biotech Hunter | Biotech Hunter